tirzepatide and parkinson's disease Frontiers Frontiers | Neuroprotective effects of

Actual dosing should always be set by a prescribing physician based on your baseline labs (especially IGF-1) and response

Appetite changes come first, followed by weight loss that tends to build as the dose increases over several months

One weeks treatment with the long-acting glucagon-like peptide 1 derivative liraglutide (NN2211) markedly improves 24-h glycemia and alpha- and beta-cell function and reduces endogenous glucose release in patients with type 2 diabetes.Diabetes 53:1187-1194, 2004

Use of these therapies is lower among socioeconomically disadvantaged and minoritized populations, largely due to cost and structural barriers

JAMA 331 , 384824945 (2024)